Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
Ultragenyx Pharmaceutical earned Food and Drug Administration approval for the ultra- rare disease drug Mepsevii.
The Food and Drug Administration on Thursday approved Genentech's hemophilia drug Hemlibra.
Express Scripts pens deal with digital health startup to treat people with chronic pulmonary disease
Express Scripts, a U.S. pharmacy benefits manager, and Propeller Health, a Madison, Wis.-based startup, are joining forces to advance treatment for patients with chronic respiratory problems, according to CNBC.
Here are seven articles Becker's Hospital Review published in the last week, highlighting the national saline bag shortage and Amazon's intentions for its state pharmacy licenses, among other topics.
The Federal Trade Commission on Tuesday ordered Abbott Laboratories to divest two medical device product lines to settle a complaint that the company's $8.3 billion acquisition of Alere is anticompetitive.
Physio-Control, a Redmond, Wash.-based provider of external defibrillators and emergency medical response products, recalled about 14,200 electrodes due to packaging issues, according to a Food and Drug Administration safety alert.
Cardinal Health on Tuesday signed a definitive agreement to divest its Cardinal Health China business to Shanghai Pharmaceuticals Holding Co. for $1.2 billion.
AstraZeneca on Wednesday earned Food and Drug Administration approval for its asthma drug Fasenra.
Ontario, Calif.-based Prime Healthcare selected HealthTrust, a Nashville, Tenn.-based healthcare performance improvement company, as its exclusive group purchasing organization.
Acorda Therapeutics paused clinical trials of its Parkinson's disease drug, tozadenant, after reporting five patient deaths, according to Reuters.